ArticleJournal of fluorescence2026
Glutathione-Modified MoS
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Achieving accurate detection of dual metal ions remains crucial challenging in the domains of ion sensing and cell imaging. Herein, glutathione (GSH)-modified MoS2 quantum dots (QDs) were synthesized via a simple one-step hydrothermal method. Upon excitation at 326 nm, the GSH-MoS2 QDs emit blue fluorescence and exhibit significant fluorescence quenching in the presence of Fe³⁺ and Ag⁺ ions, with a linear response at low concentrations. The detection limits for Fe3+ and Ag+ were determined to be 105 nM and 67.7nM, respectively. Fluorescence lifetime measurements reveal a decrease upon addition of Fe3+ and Ag+ decreasing from 6.37 ns to 6.25 ns and 5.91 ns respectively, which suggests that the fluorescence quenching mechanism of GSH-MoS2 QDs is likely due to a combination of both static and Förster Resonance Energy Transfer (FRET) processes for Fe3+ and Ag+. The absolute fluorescence quantum yield of GSH-MoS2 QDs was determined to be 11.13%. Furthermore, GSH-MoS2 QDs exhibit low cytotoxicity and good biocompatibility, and are successfully applied for the detection of Fe3+ and Ag+ ions in living cells, highlighting that GSH-MoS2 QDs have potential for use as fluorescent probes in biological sensing and cell imaging applications.
Indexed as
Identifiers
41843334What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.